59 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
Diabetic Peripheral Neuropathy - Pharmacotherapy

Peripheral neuropathy is a common microvascular complication of diabetes. In clinic patients
Diabetic Peripheral ... complication of diabetes ... clinic patients should ... #Pharmacology # ... Management #Medications
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... risks, and therapy should ... #pharmacology #pharmacotherapy ... table #comparison #management
Anterior Shoulder Dislocation - ED Management
The shoulder is the most commonly dislocated major joint, 95% of
Dislocation - ED ... Management The ... common major joint dislocation ... intraarticular injection ... #Dislocation #Anterior
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
HIV aged 21–29 should ... • Pap test should ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
CNS Infection in HIV / AIDS - Differential Diagnosis Framework

Principles of HIV-Associated CNS Opportunistic Infections:
 •
Most CNS opportunistic ... • CNS opportunistic ... • Diagnosis should ... antiretroviral therapy should ... Generally >3 cm diameter
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
to treat Type 2 Diabetes ... They work primarily ... upset (since it works ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... /day or weekly injection ... • Association with ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology